Last updated on May 2020

A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Bipolar Disorder | Endogenous depression | Depression
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients with depressive symptoms of bipolar disorder
  • Patients who have previously not been treated with quetiapine fumarate (immediate-release formulations of quetiapine fumarate and Bipresso Extended-Release Tablets)

Exclusion Criteria:

  • None

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.